BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 3, 2008
View Archived Issues
Coffee, tea reduce cerebral infarction risk in male smokers
Read More
Caloric intake reduced with AC-2307 in obese subjects
Read More
ARISE trial data, mechanism of action study reported for AGI-1067
Read More
Benefits seen with metreleptin in patients with nonalcoholic steatohepatitis
Read More
Pfizer launches Toviaz once-daily treatment for the symptoms of overactive bladder
Read More
Gemin X closes series C financing to advance registration of obatoclax
Read More
FDA grants DuoCort orphan drug designation for adrenal insufficiency
Read More
FDA grants orphan drug designation for Marqibo in metastatic uveal melanoma
Read More
EMEA accepts for review UCB's MAA for Cimzia in rheumatoid arthritis
Read More
Repros initiates phase IIb comparative study of Androxal and Testim for male fertility
Read More
Halozyme reports positive results from phase I/IIa clinical trial of Chemophase
Read More
Genmab receives milestone payment from GSK for initiation of phase II study of ofatumumab
Read More
FDA accepts for review Acusphere's NDA for Imagify in coronary artery disease
Read More
Alpharma resubmits NDA for Embeda to FDA
Read More
PM-00104 shows preclinical activity against multiple myeloma via induction of p53
Read More
Roche reports results from pilot study of NT-proBNP in predicting CV-AE
Read More
GSK presents update on application to FDA for approval of cervical cancer vaccine Cervarix
Read More
FDA approves VGX's IND application for VGX-3100 DNA vaccine for cervical cancer
Read More
XTL completes patient randomization into phase IIb study of bicifadine
Read More
Epix resubmits Vasovist NDA to FDA
Read More
Ore files IND application with FDA for GL-1001 in inflammatory bowel disease
Read More
Preliminary response rate data reported for discontinued phase III trial of CoFactor
Read More
New agents for Alzheimer's disease and other neurological disorders reported in recent patents
Read More
Lev to submit Cinryze application to the EMEA for hereditary angioedema
Read More
New antiobesity agents claimed in recent patents
Read More